Wells Fargo & Company Merck & Co., Inc. Put Options Transaction History

Wells Fargo & Company

14 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q2 2024 Aug 13, 2024	BUY	$123.8 - $132.96 $1.58 Million - $1.7 Million	12,800 Added 31.68%	53,200 $6.59 Million
Q1 2024 May 10, 2024	SELL	$113.24 - $131.95 $27.8 Million - $32.4 Million	-245,700 Reduced 85.88%	40,400 $5.33 Million
Q4 2023 Feb 09, 2024	BUY	$100.18 - $109.02 $26 Million - $28.3 Million	259,300 Added 967.54%	286,100 $31.2 Million
Q2 2023 Aug 15, 2023	SELL	$108.61 - $118.38 $249,803 - $272,274	-2,300 Reduced 7.9%	26,800 $3.09 Million
Q1 2023 May 12, 2023	SELL	$102.94 - $114.86 $17.4 Million - $19.4 Million	-168,900 Reduced 85.3%	29,100 $3.1 Million
Q4 2022 Feb 13, 2023	SELL	$87.44 - $112.11 $42.9 Million - $55 Million	-490,300 Reduced 71.23%	198,000 $22 Million
Q3 2022 Nov 14, 2022	BUY	$84.53 - $94.96 $41.3 Million - $46.4 Million	488,400 Added 244.32%	688,300 $59.3 Million
Q2 2022 Aug 12, 2022	BUY	$83.49 - $94.64 $2.97 Million - $3.37 Million	35,600 Added 21.67%	199,900 $18.2 Million
Q1 2022 May 16, 2022	BUY	$73.51 - $82.4 $10.4 Million - $11.7 Million	141,900 Added 633.48%	164,300 $13.5 Million
Q1 2021 May 13, 2021	BUY	$68.86 - $81.11 $185,922 - $218,997	2,700 Added 13.71%	22,400 $1.73 Million
Q4 2020 Feb 09, 2021	BUY	$71.77 - $79.65 $1.24 Million - $1.38 Million	17,300 Added 720.83%	19,700 $213,000
Q3 2020 Nov 05, 2020	BUY	$73.18 - $82.95 $58,544 - $66,360	800 Added 50.0%	2,400 $4,000
Q2 2020 Aug 13, 2020	SELL	$70.42 - $80.13 $105,630 - $120,195	-1,500 Reduced 48.39%	1,600 $2,000
Q1 2020 May 14, 2020	BUY	$63.36 - $87.82 $196,416 - $272,242	3,100 New	3,100 $4,000

3,807

1.92B

13.4M

10.6M

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $258B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

Stay updated on Wells Fargo & Company with notifications on news.